Drug
Raloxifene clinical trials
Also written Evista and LY139481.
- studies test it
- 46
- open now
- 2
- in phase 3
- 11
- first study started
- 1994
Keep track of what changes. Save the raloxifene studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Combined with it in one product
Studies by the year they started
45 studies that test it; most in 1998 (4)
| Year | Studies |
|---|---|
| 1994 | 1 |
| 1998 | 4 |
| 1999 | 1 |
| 2000 | 2 |
| 2001 | 4 |
| 2002 | 3 |
| 2003 | 2 |
| 2004 | 2 |
| 2006 | 4 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 1
- Phase 2
- 11
- Phase 3
- 11
- Phase 4
- 19
- No phase
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 12 · Other 34
Eli Lilly and Company (9) · The Alfred (3) · Fundació Sant Joan de Déu (2) · Mayo Clinic (2) · University of Wisconsin, Madison (2) · Massachusetts General Hospital (1) · Hospital de Clinicas de Porto Alegre (1) · Yonsei University (1)
Often tested with
Tested in the same studies.
Teriparatide (5) · Alendronate (2) · Cholecalciferol (2) · Bicalutamide (2) · Tamoxifen (1) · Goserelin (1) · Strontium ranelate (1) · Zoledronic Acid (1)
Studies
Open first, then newest update. How each study uses raloxifene is read from its arms, and is right about nine times in ten.
Testing it · 46
- Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the BrainRecruitingPhase 2The University of Texas Health Science Center at San AntonioNCT07470606Written as Raloxifene
- New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic HyperplasiaRecruitingPhase 2Beth Israel Deaconess Medical CenterNCT06944145Written as raloxifene
- Induction of Ovulation With Raloxifene or Clomiphene Citrate in Polycystic Ovarian SyndromeCompletedPhase 3Hospital de Clinicas de Porto AlegreNCT00427700Written as raloxifene
- Raloxifene as an Adjuvant Treatment of the Negative Symptoms of Schizophrenia in Post-menopausal WomenCompletedPhase 3Fundació Sant Joan de DéuNCT01573637Written as Raloxifene
- Effect of Raloxifene Plus Cholecalciferol and Cholecalciferol Alone on the Bone Mineral Density in Postmenopausal Women With OsteopeniaCompletedPhase 4Yonsei UniversityNCT05386784Written as Raloxifene plus cholecalciferol
- Multicenter Double Blind, Parallel-group Phase 2/3 Trial, to Study Raloxifene in Adult COVID-19 Patients.CompletedPhase 2/3Dompé Farmaceutici S.p.ANCT05172050Written as Raloxifene
- Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?CompletedPhase 4The AlfredNCT01481883Written as Raloxifene Hydrochloride
- Comparative Antiresorptive Efficacy Discontinuation of DenosumabActive, not recruitingPhase 4Massachusetts General HospitalNCT03623633Written as raloxifene
- Clinical Trial on the Efficacy of Raloxifene on Disease Activity in Rheumatoid ArthritisCompletedNot applicableSara Saeidi ShahriNCT02982083Written as Raloxifene hydrochloride
- Raloxifene Augmentation in Patients With a Schizophrenia Spectrum DisorderCompletedPhase 3Iris SommerNCT03043820Written as Raloxifene
- Selective Estrogen Receptor Modulators for Women of Child-bearing Age With SchizophreniaCompletedPhase 4The AlfredNCT02354001Written as Raloxifene hydrochloride
- Adjunctive Selective Estrogen Receptor Modulators on Negative and Cognitive Symptoms of Schizophrenia in WomenCompletedPhase 4Shanghai Mental Health CenterNCT03418831Written as Raloxifene Hydrochloride
- Bicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing SurgeryWithdrawnPhase 2Mayo ClinicNCT03147196Written as Raloxifene Hydrochloride
- Osteoporosis Treatment in Post-menopausal WomenStatus unknownPhase 4Taichung Veterans General HospitalNCT03006003Written as Raloxifene
- Nutritional Supplements and Hormonal Manipulations for Breast Cancer PreventionCompletedNot applicableMilton S. Hershey Medical CenterNCT00723398Written as Raloxifene 60 Mg Oral Tablet
- Efficacy Study of Raloxifene to Induce Ovulation in Polycystic Ovarian SyndromeTerminatedNot applicableBruce LesseyNCT01607320Written as Raloxifene
- Cognition in the Study of Tamoxifen and RaloxifeneCompletedPhase 3Wake Forest UniversityNCT00687102Written as raloxifene
- Bicalutamide and Raloxifene in Treating Patients With Metastatic or Hormone-Refractory Prostate CancerCompletedEarly Phase 1Mayo ClinicNCT01050842Written as raloxifene
- The Safety and Effectiveness of Surgery With or Without Raloxifene for the Treatment of Pelvic Pain Caused by EndometriosisCompletedPhase 2Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NCT00001848Written as Raloxifene
- Raloxifene and Rimostil for Perimenopause-Related DepressionCompletedPhase 4National Institute of Mental Health (NIMH)NCT00030147Written as Raloxifene
See all 46 studies that test raloxifene →
Given in every arm · 4 — raloxifene is usual care beside what is tested
- Evaluating the Pharmacokinetic Characteristics of AD-101 in Healthy VolunteersCompletedPhase 1Addpharma Inc.NCT03764462Written as Raloxifene 60mg
- Evaluating the Pharmacokinetic Characteristics of AD-102 in Healthy VolunteersCompletedPhase 1Addpharma Inc.NCT03824171Written as Raloxifene 60mg/Cholecalciferol 800IU
- DP-R213 Phase 1 Pharmacokinetics StudyCompletedPhase 1Alvogen KoreaNCT03010267Written as Raloxifene
- DP-R213 Pharmacokinetics StudyCompletedPhase 1Alvogen KoreaNCT02762643Written as Raloxifene
As the comparator · 5 — what is tested is compared with raloxifene
- 3-year Study of Menostar Versus Evista to Prevent Osteoporosis in Post-menopausal WomenCompletedPhase 3BayerNCT00310531Written as Raloxifene
- Comparison of Raloxifene and Lasofoxifene - A Randomized, Blinded Study of These Drugs and Placebo on Bone LossCompletedPhase 3Ligand PharmaceuticalsNCT00163137Written as raloxifene
- Risedronate vs Raloxifene in Hormone Replacement Therapy DiscontinuationTerminatedPhase 4SanofiNCT00790101Written as Raloxifene
- Study Comparing Arzoxifene With Raloxifene in Women After Menopause With OsteoporosisCompletedPhase 3Eli Lilly and CompanyNCT00383422Written as Raloxifene
- Study Evaluating Safety and Efficacy of Bazedoxifene/Conjugated Estrogens Combinations in Postmenopausal WomenCompletedPhase 3Wyeth is now a wholly owned subsidiary of PfizerNCT00675688Written as Raloxifene
Codes
What other systems call raloxifene · ClinicalTrials.gg INT008774
- MeSH (NLM) D020849Raloxifene HydrochlorideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) YX9162EO3IRALOXIFENEConfirmed FDA, NLM, Wikidata
- RxNorm 72143Confirmed FDA, Wikidata
- Wikidata Q425223raloxifeneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1518RaloxifeneOne source FDA
- DrugBank DB00481One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D020849 | Raloxifene Hydrochloride | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | YX9162EO3I | RALOXIFENE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 72143 | — | Confirmed FDA, Wikidata |
| Wikidata | Q425223 | raloxifene | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1518 | Raloxifene | One source FDA |
| DrugBank | DB00481 | — | One source Wikidata |
Also registered as raloxifene hydrochloride (UNII 4F86W47BR6 · RxNorm 166551).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.